Background We analyzed the reactions to first range treatment and clinical August 30, 2017 Billie Young Background We analyzed the reactions to first range treatment and clinical results of metastatic breasts cancer individuals treated with palliative doxorubicin/cyclophosphamide (AC) based on molecular... Read More
